Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Are we still talking to our patients with schizophrenia?

Keith SJ.

Am J Psychiatry. 2006 Mar;163(3):362-4. No abstract available.

PMID:
16513853
2.

Using a medical model with psychotic patients.

Kontos N, Freudenreich O, Querques J.

Am J Psychiatry. 2006 Sep;163(9):1646-7; author reply 1647. No abstract available.

PMID:
16946200
3.

Cognitive behavior therapy for schizophrenia.

Turkington D, Kingdon D, Weiden PJ.

Am J Psychiatry. 2006 Mar;163(3):365-73. Review.

PMID:
16513854
4.

Treatment of agitation in patients with schizophrenia.

Marder SR.

J Clin Psychiatry. 2008 Jun;69(6):e17.

5.

Contemporary issues in the field.

Gorman JM.

CNS Spectr. 2005 Dec;10(12):929. No abstract available.

PMID:
16344828
6.

Drowning in numbers-what psychiatrists mean when talking to patients about probabilities of risks and benefits of medication.

Hamann J, Mendel R, Bühner M, Leucht S, Kissling W.

Eur Psychiatry. 2011 Mar;26(2):130-1. doi: 10.1016/j.eurpsy.2010.09.004. Epub 2010 Nov 9. No abstract available.

PMID:
21067902
7.

Poison or cure: meanings of medication in schizophrenia.

Rosenfield PJ.

J Am Acad Psychoanal Dyn Psychiatry. 2007 Summer;35(2):189-201.

PMID:
17650972
8.

Drug and psychosocial curricula for psychiatry residents for treatment of schizophrenia: part II.

Liberman RP.

Psychiatr Serv. 2005 Jan;56(1):28-30. Review. No abstract available.

PMID:
15637187
9.

The psychotherapy of schizophrenia: an NIMH program.

Friedman RJ, Gunderson JE, Feinsilver DB.

Am J Psychiatry. 1973 Jun;130(6):674-7. No abstract available.

PMID:
4144981
10.

[Compliance with treatment in schizophrenia and mood disorders].

Sorvaniemi M, Kampman O.

Duodecim. 2000;116(3):277-84. Review. Finnish. No abstract available.

PMID:
11764451
11.

A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder.

Byerly MJ, Fisher R, Carmody T, Rush AJ.

J Clin Psychiatry. 2005 Aug;66(8):997-1001.

PMID:
16086614
12.

Cognitive-behavioral therapy and clozapine for clients with treatment-refractory schizophrenia.

Pinto A, La Pia S, Mennella R, Giorgio D, DeSimone L.

Psychiatr Serv. 1999 Jul;50(7):901-4. No abstract available.

PMID:
10402608
13.

The management of difficult to treat patients with schizophrenia, using non-drug therapies.

Kuipers E.

Br J Psychiatry Suppl. 1996 Dec;(31):41-51. Review. No abstract available.

PMID:
8968654
14.

Establishing therapeutic contact with schizophrenics: a supervisory approach.

Huszonek JJ.

Am J Psychother. 1987 Apr;41(2):185-93.

PMID:
3605452
15.

Schizophrenia treatment guidelines in the United States.

Moore TA.

Clin Schizophr Relat Psychoses. 2011 Apr;5(1):40-9. doi: 10.3371/CSRP.5.1.6. Review.

PMID:
21459738
16.

Clinical practice guidelines. Treatment of schizophrenia.

Canadian Psychiatric Association..

Can J Psychiatry. 2005 Nov;50(13 Suppl 1):7S-57S. No abstract available.

PMID:
16529334
17.

Cognitive-behavioral therapy for medication-resistant symptoms.

Garety PA, Fowler D, Kuipers E.

Schizophr Bull. 2000;26(1):73-86. Review.

PMID:
10755670
18.

Cognitive behavior therapy for schizophrenia: a meta-analytical review of randomized controlled trials.

Sarin F, Wallin L, Widerlöv B.

Nord J Psychiatry. 2011 Jun;65(3):162-74. doi: 10.3109/08039488.2011.577188.

PMID:
21563994
19.

Treatment resistance in schizophrenia.

Mirza S, Babu VS, Vithayathil E.

Br J Psychiatry. 1993 Sep;163:409-10. No abstract available.

PMID:
8104654
20.

Treatment resistance and other complicating factors in the management of schizophrenia.

Strassnig MT, Harvey PD.

CNS Spectr. 2014 Dec;19 Suppl 1:16-23; quiz 13-5, 24. doi: 10.1017/S1092852914000571. Epub 2014 Nov 20. Review.

PMID:
25410772

Supplemental Content

Support Center